Study Details
A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4
Clinicaltrials.gov ID
Astellas Study ID
ASG-22CE-13-2
EudraCT ID
N/A
Condition
Bladder Cancer
Phase
Phase 1
Age
18 years - N/A
Sex
Female & Male
Product
enfortumab vedotin
Type
Interventional
Trial Dates
Jun 2014 - Dec 2022
Masking
None (Open Label)
Enrollment number
213
A Phase 1 Study of the Safety and Pharmacokinetics of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4
Study summary
Get More Information
Would you like more information about clinical trial sites that are recruiting participants for A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4? Contact us by filling our your information to the right and we’ll respond to you.
Locations
Site CA00001
Edmonton, Canada, T6G 1Z2
Site US00008
Tampa, United States, 33612
Site US00017
Aurora, United States, 80045
Site US00001
Seattle, United States, 98109
Site CA00010
Toronto, Canada, M5G 2M9
Site US00020
Pittsburgh, United States, 15232
Site US00005
Ann Arbor, United States, 48109
Site US00007
Miami, United States, 33136
Site US00009
Madison, United States, 53792
Site US00019
Stanford, United States, 94305
Site CA00011
Calgary, Canada, T2N 4N2
Site US00014
Baltimore, United States, 21201
Site US00021
Las Vegas, United States, 89119
Site US00025
Spokane, United States, 99208
Site US00004
Fairway, United States, 66205
Site US00024
Fairfax, United States, 22031
Site US00026
Omaha, United States, 68130
Site US00013
Philadelphia, United States, 19111
Site US00006
New Haven, United States, 06520
Site US00002
New York, United States, 10065
Site US00022
Dallas, United States, 75251
Site US00003
Detroit, United States, 48201
Site US00023
Chapel Hill, United States, 27599
Site US00018
New York, United States, 10029
Site US00027
Harvey, United States, 60426
Site US00015
Milwaukee, United States, 53226
Site US00016
Indianapolis, United States, 46202
Site US00012
Los Angeles, United States, 90033